companydata.dkcompanydata.dk

ANAPA BIOTECH A/S: Financial statements 2013

CVR: 27585167

Source: annual report 2013, Danish Business Authority

01/01/2013 – 31/12/2013

ANAPA BIOTECH A/S (CVR 27585167) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK -2,381,000 and a net result of DKK -2,831,000 compared with DKK -2,770,719 the year before. Equity in the 2013 report amounted to DKK 50,747,000. The solvency ratio was 94.4%. The company had 7 employees in the financial year.

Gross Profit
DKK -2,381,000
Profit/Loss
DKK -2,831,000
Equity
DKK 50,747,000
Total Assets
DKK 53,775,000
Employees
7

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2013--2.4M-2.8M50.7M7
20120-2.6M-2.8M32.5M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2013

QUANTIBACT A/S changes name to ANAPA BIOTECH A/SDec 13, 2013

On December 13, 2013, the company changed its name from QUANTIBACT A/S to ANAPA BIOTECH A/S.

Søren Morgenthaler Echwald joins ANAPA BIOTECH A/S as adm. dir.Nov 15, 2013

As of November 15, 2013, Søren Morgenthaler Echwald is registered as adm. dir. of ANAPA BIOTECH A/S.

Palle Schelde Jensen steps down as adm. dir. of ANAPA BIOTECH A/SNov 15, 2013

As of November 15, 2013, Palle Schelde Jensen has stepped down as adm. dir. of ANAPA BIOTECH A/S.

Karim Tabiti joins the board of ANAPA BIOTECH A/SMay 3, 2013

As of May 3, 2013, Karim Tabiti has joined the board of directors of ANAPA BIOTECH A/S.

ANAPA BIOTECH A/S: The 2012 annual report is outFeb 27, 2013

ANAPA BIOTECH A/S has published its annual report for 2012. Revenue came to DKK 0, and the net result was DKK -2,770,719.

About ANAPA BIOTECH A/S

ANAPA BIOTECH A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2004. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named QUANTIBACT A/S and LNA BACTERIAL DETECTION A/S. The management consists of Søren Morgenthaler Echwald. The board consists of Anette Kofod Echwald (chair), Caroline Marie Morgenthaler Echwald and Søren Morgenthaler Echwald. The company is owned by Apana Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 263,027 and a net result of DKK 488,982 compared with DKK 7,646,635 the year before. Equity in the 2025 report amounted to DKK 10,970,173.

Source: annual report 2025, Danish Business Authority